Screening for Excessive Alcohol Drinking
- 25 September 1995
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 155 (17) , 1907-1911
- https://doi.org/10.1001/archinte.1995.00430170103013
Abstract
Background: Screening medical patients for excessive alcohol drinking is important because minimal intervention by physicians is effective in reducing excessive consumption. Screening tests, such as biologic markers of alcohol consumption, should therefore be investigated to assess their validity to detect alcohol drinking. Method: Levels of carbohydrate-deficient transferrin (CDT), γ-glutamyltransferase (GGT), and mean corpuscular volume (MCV) were determined in 1202 consecutive patients (20 to 75 years old) seen at the medical emergency ward (n=552) and the primary care center (n=650) of a city and teaching hospital. Each eligible patient was administered a CAGE questionnaire (an acronym for questions regarding cutting down on drinking, annoyance at others' concern about drinking, feeling guilty about drinking, and using alcohol as an eye-opener in the morning), and for each CAGE-positive patient (score ≥1) as well as for a random sex-matched sample of CAGE-negative patients, standardized data about the recent level of alcohol drinking, morbidities, drug therapy, and smoking were recorded. The operating characteristics of CDT, GGT, and MCV were determined according to alcohol consumption and the CAGE test. Sensitivities, specificities, and receiver operating characteristic curves were computed to compare the tests at different cutoff values. Results: Levels of CDT were elevated in 21% of men and 7% of women. According to recent alcohol consumption in men (>60 g/d), the respective sensitivity and specificity of the tests were 0.58 and 0.82 for CDT, 0.69 and 0.65 for GGT, and 0.27 and 0.91 for MCV. Overall, receiver operating characteristic curves demonstrated similar performance of the three tests for screening of excessive alcohol drinking or alcohol abuse. However, in young men (Conclusions: The study suggests that CDT determination may be a useful test for screening programs of excessive alcohol drinking in young male medical patients. (Arch Intern Med. 1995;155:1907-1911)This publication has 16 references indexed in Scilit:
- Blood and Liver Markers in the Estimation of Alcohol ConsumptionPublished by Springer Nature ,1992
- Carbohydrate deficient transferrin: a marker for alcohol abuse.BMJ, 1989
- Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption.BMJ, 1988
- DESIALYLATED TRANSFERRIN AS A SEROLOGICAL MARKER OF CHRONIC EXCESSIVE ALCOHOL INGESTIONThe Lancet, 1987
- Micro Anion Exchange Chromatography of Carbohydrate‐Deficient Transferrin in Serum in Relation to Alcohol Consumption (Swedish Patent8400587–5)Alcohol, Clinical and Experimental Research, 1986
- Identification and Intervention of Heavy Drinking in Middle‐Aged Men: Results and Follow‐up of 24–60 Months of Long‐Term Study with Randomized ControlsAlcohol, Clinical and Experimental Research, 1983
- Is serum gamma-glutamyltransferase a misleading test?BMJ, 1983
- MEAN CELL VOLUME AND GAMMA-GLUTAMYL-TRANSPEPTIDASE AS MARKERS OF DRINKING IN WORKING MENThe Lancet, 1981
- Alcohol consumption in a healthy population. Relationship to gamma-glutamyl transferase activity and mean corpuscular volumePublished by American Medical Association (AMA) ,1981
- The Michigan Alcoholism Screening Test: The Quest for a New Diagnostic InstrumentAmerican Journal of Psychiatry, 1971